Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

被引：0
|
作者：
Alexandre R Zlotta
Claude Schulman
机构：
[1] Senior Faculty in Urology at the University Clinics of Brussels in Brussels,Chief of the Department of Urology at Erasme Hospital
[2] University Clinics of Brussels,undefined
[3] and a Professor of Urology at the University of Brussels,undefined
来源：
Nature Clinical Practice Urology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：474 / 475
页数：1
相关论文
共 50 条
  • [21] Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
    Mason, Malcolm D.
    Parulekar, Wendy R.
    Sydes, Matthew R.
    Brundage, Michael
    Kirkbride, Peter
    Gospodarowicz, Mary
    Cowan, Richard
    Kostashuk, Edmund C.
    Anderson, John
    Swanson, Gregory
    Parmar, Mahesh K. B.
    Hayter, Charles
    Jovic, Gordana
    Hiltz, Andrea
    Hetherington, John
    Sathya, Jinka
    Barber, James B. P.
    McKenzie, Michael
    El-Sharkawi, Salah
    Souhami, Luis
    Hardman, P. D. John
    Chen, Bingshu E.
    Warde, Padraig
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2143 - U170
  • [22] Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer
    Nambudiri, Vinod E.
    Keating, Nancy L.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 531 - 537
  • [23] Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
    Azoulay, Laurent
    Yin, Hui
    Benayoun, Serge
    Renoux, Christel
    Boivin, Jean-Francois
    Suissa, Samy
    EUROPEAN UROLOGY, 2011, 60 (06) : 1244 - 1250
  • [24] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1822 - 1832
  • [25] Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
    Shore, Neal D.
    Saad, Fred
    Cookson, Michael S.
    George, Daniel J.
    Saltzstein, Daniel R.
    Tutrone, Ronald
    Akaza, Hideyuki
    Bossi, Alberto
    van Veenhuyzen, David F.
    Selby, Bryan
    Fan, Xiaolin
    Kang, Vicky
    Walling, Jackie
    Tombal, Bertrand
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2187 - 2196
  • [26] TIME TO PROGRESSION SHOULD NOT BE USED TO INFER THE ULTIMATE BENEFIT OF IMMEDIATE VERSUS DEFERRED/SALVAGE ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Studer, U. E.
    Whelan, P.
    Wimpissinger, F.
    Casselman, J.
    De Reijke, Th. M.
    Knoenagel, H.
    Madersbacher, S.
    Isorna, S.
    Sundaram, S. K.
    Collette, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 253 - 253
  • [27] Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer
    Gupta, Dipti
    Chuy, Katherine Lee
    Yang, Ji Can
    Bates, Megan
    Lombardo, Marissa
    Steingart, Richard M.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (10) : 580 - +
  • [28] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 580 - 580
  • [29] Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer
    Harrington, Joanne M.
    Schwenke, Dawn C.
    Epstein, Dana R.
    Bailey, Donald E., Jr.
    ONCOLOGY NURSING FORUM, 2014, 41 (01) : 21 - 29
  • [30] Re: Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
    Ozkan, Tayyar Alp
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (02): : 107 - 107
12345